CAMPA, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 14.985
AS - Asia 6.908
EU - Europa 4.693
SA - Sud America 1.277
Continente sconosciuto - Info sul continente non disponibili 785
AF - Africa 298
OC - Oceania 25
Totale 28.971
Nazione #
US - Stati Uniti d'America 14.555
SG - Singapore 2.136
CN - Cina 1.692
IT - Italia 1.571
HK - Hong Kong 1.285
BR - Brasile 1.008
VN - Vietnam 790
DE - Germania 685
SE - Svezia 554
BG - Bulgaria 383
FR - Francia 319
FI - Finlandia 266
CA - Canada 258
GB - Regno Unito 242
RU - Federazione Russa 206
IN - India 157
JP - Giappone 144
TR - Turchia 140
KR - Corea 130
AR - Argentina 105
AT - Austria 105
BD - Bangladesh 89
CI - Costa d'Avorio 79
UA - Ucraina 66
IQ - Iraq 57
MX - Messico 54
MA - Marocco 53
EC - Ecuador 50
PK - Pakistan 45
ZA - Sudafrica 44
NL - Olanda 41
IE - Irlanda 38
SN - Senegal 36
ID - Indonesia 34
JM - Giamaica 33
CO - Colombia 32
BE - Belgio 30
SA - Arabia Saudita 29
UZ - Uzbekistan 28
CH - Svizzera 27
ES - Italia 26
PL - Polonia 25
VE - Venezuela 22
CR - Costa Rica 21
AU - Australia 20
MY - Malesia 20
EE - Estonia 19
PY - Paraguay 18
CZ - Repubblica Ceca 17
EG - Egitto 16
AE - Emirati Arabi Uniti 15
CL - Cile 15
DZ - Algeria 15
TN - Tunisia 13
HU - Ungheria 12
JO - Giordania 12
PH - Filippine 12
GR - Grecia 11
PE - Perù 10
TT - Trinidad e Tobago 10
AL - Albania 9
AZ - Azerbaigian 9
IL - Israele 9
KE - Kenya 9
NP - Nepal 9
BB - Barbados 8
LB - Libano 8
OM - Oman 8
PS - Palestinian Territory 8
UY - Uruguay 8
LT - Lituania 7
PA - Panama 7
PT - Portogallo 7
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
NG - Nigeria 6
AO - Angola 5
BO - Bolivia 5
ET - Etiopia 5
GT - Guatemala 5
NI - Nicaragua 5
NZ - Nuova Zelanda 5
SV - El Salvador 5
EU - Europa 4
IR - Iran 4
KG - Kirghizistan 4
RO - Romania 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BS - Bahamas 3
HN - Honduras 3
KH - Cambogia 3
KW - Kuwait 3
NO - Norvegia 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
BA - Bosnia-Erzegovina 2
GA - Gabon 2
Totale 28.139
Città #
Ashburn 1.594
Hong Kong 1.260
Singapore 1.257
Woodbridge 1.215
Fairfield 1.180
Dallas 970
Houston 767
Ann Arbor 750
San Jose 697
Santa Clara 683
Chandler 557
Seattle 474
Shanghai 421
Wilmington 411
Sofia 382
Cambridge 374
Council Bluffs 359
New York 328
Milan 296
Beijing 295
Boardman 276
Los Angeles 243
Serra 217
Ho Chi Minh City 192
Hefei 191
Munich 187
Princeton 175
Lauterbourg 161
Hanoi 150
Lawrence 150
Ottawa 149
Medford 146
Frankfurt am Main 135
Florence 130
Tokyo 128
Seoul 117
Des Moines 113
Pisa 113
Bremen 107
Helsinki 106
Rome 94
Redondo Beach 89
Buffalo 86
São Paulo 86
Abidjan 79
Dong Ket 78
Nuremberg 78
Nanjing 73
Vienna 69
Istanbul 67
San Diego 67
London 65
Jacksonville 56
Dearborn 47
Rio de Janeiro 42
Falls Church 41
Phoenix 41
Lappeenranta 40
Columbus 39
Lucca 38
Ogden 37
Toronto 37
Casablanca 36
Dakar 36
Chicago 35
Izmir 35
San Francisco 33
Guangzhou 28
Brussels 27
Boulder 26
Düsseldorf 26
Atlanta 25
Nanchang 25
The Dalles 25
Haiphong 24
Orem 24
Redwood City 24
Tashkent 24
Turku 24
Changsha 23
Hyderabad 23
Pune 23
Amsterdam 22
Baghdad 21
Brasília 21
Curitiba 21
Fuzhou 21
Guarulhos 21
Marseille 21
Quito 21
Warsaw 21
Da Nang 20
Montreal 20
Salt Lake City 20
Shenyang 20
Johannesburg 19
Belo Horizonte 18
Jiaxing 18
Kingston 18
Manchester 18
Totale 19.712
Nome #
Maternal anthropometric variables and clinical factors shape neonatal microbiome 347
Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium 307
Exploring the Neandertal legacy of pancreatic ductal adenocarcinoma risk in Eurasians 291
Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer 287
A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk 258
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief 253
Global diversity in the TAS2R38 bitter taste receptor: revisiting a classic evolutionary PROPosal 251
Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk 221
A gene-wide investigation on polymorphisms in the ABCG2/BRCP transporter and susceptibility to colorectal cancer 217
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. 216
Differential expression of secretory aspartyl proteinase genes (SAP1-10) in oral Candida albicans isolates with distinct karyotypes 214
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). 208
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium. 208
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancer 205
Association between taste receptor (TAS) genes and the perception of wine characteristics 197
Polymorphic variants within non-coding RNA and risk of pancreatic ductal adenocarcinoma 195
Association between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian origin 194
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival 194
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. 193
Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium. 191
Outcome of experimental rat vaginitis by Candida albicans isolates with different karyotypes 190
Functional single nucleotide polymorphisms within the cyclindependent kinase inhibitor 2A/2B region affect pancreatic cancer risk 188
MAP3K7 and GSTZ1 are associated with human longevity: a two-stage case-control study using a multilocus genotyping 187
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 181
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer 178
A gene-wide investigation on polymorphisms in the taste receptor 2R14 (TAS2R14) and susceptibility to colorectal cancer 178
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 177
A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis 177
DNA microarray based on arrayed-primer extension technique for identification of pathogenic fungi responsible for invasive and superficial mycoses 176
Interaction between functional polymorphic variants in cytokine genes, established risk factors and susceptibility to basal cell carcinoma of skin. 175
Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study 173
Bitter taste receptor polymorphisms and human aging. 171
Lights and shadows of molecular pathology and immunotherapy in adjuvant setting of patients with pancreatic ductal adenocarcinoma: Tumor volume and microsatellite instability inversely affect early progression free survival 170
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes 169
Single nucleotide polymorphism detection by optical DNA-based sensing coupled with whole genomic amplification. 168
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. 168
CD69, a New Potential Clinical Marker in Multiple Myeloma 168
Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort 168
Associations between pancreatic expression quantitative trait loci (eQTLs) and pancreatic ductal adenocarcinoma risk 168
Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-Results from the EPIC cohort study. 166
TAS2R38 polymorphisms, Helicobacter pylori infection and susceptibility to gastric cancer and premalignant gastric lesions 166
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk 166
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients 165
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. 164
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 163
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 161
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression? 161
Two susceptibility loci identified for prostate cancer aggressiveness. 160
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. 159
Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. 158
Population-specific association of genes for telomere-associated proteins with longevity in an Italian population 158
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. 158
A pleiotropy scan to discover new susceptibility loci for pancreatic ductal adenocarcinoma 157
Pancreatic cancer susceptibility loci and their role in survival. 157
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. 157
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. 157
Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. 157
Additive interactions between susceptibility single-nucleotide polymorphisms identified in genome-wide association studies and breast cancer risk factors in the Breast and Prostate Cancer Cohort Consortium. 156
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. 155
Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 155
Genetic risk variants associated with in situ breast cancer 154
A genome-wide "pleiotropy scan" does not identify new susceptibility loci for estrogen receptor negative breast cancer. 153
Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors 153
POMC and TP53 genetic variability and risk of basal cell carcinoma of skin: Interaction between host and genetic factors. 153
Genetic and non-genetic risk factors for early-onset pancreatic cancer 152
Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). 152
The genetic variant SLC2A1-rs1105297 is associated with the differential analgesic response to a glucose-based treatment in newborns 151
Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: a case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium. 151
Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer 151
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis 151
SLC22A3 polymorphisms do not modify pancreatic cancer risk, but may influence overall patient survival 150
MICROSATELLITE INSTABILITY AND TUMOR VOLUME INVERSELY AFFECT EARLY PROGRESSION FREE SURVIVAL IN ADJUVANT SETTING OF PATIENTS WITH PANCREATIC DUCTAL ADENOCARCINOMA: LIGHTS AND SHADOWS OF MOLECULAR PATHOLOGY AND IMMUNOTHERAPY 150
Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study 150
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. 149
Germline genetic variability in pancreatic cancer risk and prognosis 149
Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. 148
Common germline polymorphisms associated with breast cancer-specific survival. 148
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer 148
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 147
Genetically predicted gut bacteria, circulating bacteria-associated metabolites and pancreatic ductal adenocarcinoma: a Mendelian randomisation study 147
Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium. 147
Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation 147
Analysis of exposome and genetic variability suggests stress as a major contributor for development of pancreatic ductal adenocarcinoma 146
A polygenic risk score for multiple myeloma risk prediction 146
Genetically determined telomere length and multiple myeloma risk and outcome 146
Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility 146
Replication of five prostate cancer loci identified in an Asian population--results from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). 145
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. 145
Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79 000 women. 144
Identification of novel genetic loci for risk of multiple myeloma by functional annotation 143
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization 143
Association of common polymorphisms in inflammatory genes with risk of developing cancers of the upper aerodigestive tract. 143
Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC). 143
Role of OPRM1, clinical and anthropometric variants in neonatal pain reduction 143
A genome-wide pleiotropy scan for prostate cancer risk. 142
Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms 141
Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium. 139
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. 139
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 139
Polymorphisms in the gene regions of the adaptor complex LAMTOR2/LAMTOR3 and their association with breast cancer risk. 138
Totale 17.205
Categoria #
all - tutte 87.330
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.330


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.680 0 0 57 99 315 229 82 84 160 82 102 470
2022/20232.012 256 199 112 234 211 233 22 154 365 12 191 23
2023/20241.691 134 157 197 77 240 312 49 64 40 40 163 218
2024/20255.996 12 200 113 256 443 698 534 352 609 851 678 1.250
2025/20268.309 566 952 1.140 743 646 656 1.379 410 539 700 264 314
2026/20271.463 274 714 475 0 0 0 0 0 0 0 0 0
Totale 28.971